Greenmed Wellness Center

Greenmed Wellness Center At Green Med Wellness Center our patients are our priority! Come check us out! �
We are located at 6464 E Tanque Verde Tucson AZ 85712

07/18/2024

FDA Cracks Down on Cannabis Companies Mimicking Popular Snack Brands
Posted July 18, 2024 on Black Enterprise

ImageFDA Cracks Down on Cannabis Companies Mimicking Popular Snack Brands
The FDA isn’t here for Cannabis companies branding THC products that favor popular snacks.
The warning comes after growing reports of harmful delta-8 THC ingestion by children and unknowing adults.

The Food and Drug Administration (FDA) and Federal Trade Commission (FTC) have issued warnings to cannabis companies about their continued selling of “copycat” food products containing delta-8 THC.

According to the FDA website, delta-8 tetrahydrocannabinol, or delta-8 THC, is a psychoactive compound found in the cannabis sativa plant, which includes both ma*****na and h**p varieties. Although delta-8 THC is one of over 100 cannabinoids naturally produced by the cannabis plant, it is present in very small amounts. However, nearly all the delta-8 THC available for purchase is lab-made using cannabidiol (CBD) from h**p plants, along with various chemicals. This synthetic delta-8 THC is much more potent than the small amounts naturally found in the cannabis plant.

“It is important for consumers to be aware that Delta-8 THC products have not been evaluated or approved by the FDA for safe use in any context. They may be marketed in ways that put the public health at risk and should especially be kept out of reach of children and pets,” the FDA stressed.

Five companies, including Hippy Hood and Earthly Hemps, received the warnings, stating that they are violating the Federal Food, Drug, and Cosmetic Act. These products could potentially confuse buyers, particularly minors, into buying the popular snacks without realizing that they contain delta-8 THC. These THC-infused products look nearly identical to name-brand items, such as Chips Ahoy! or Flamin’ Hot Cheetos.

The FDA noted the potential danger of leaving these products on the market.

“Inadequate or confusing labeling can result in children or unsuspecting adults consuming products with a strong resemblance to popular snacks and candies that contain delta-8 THC without realizing it,” explained FDA Principal Deputy Commissioner Namandjé Bumpus, Ph.D., in the news release.

She added, “As accidental ingestion and/or overconsumption of Delta-8 THC-containing products could pose considerable health risks, the companies who sell these illegal products are demonstrating complete neglect for consumer safety. The FDA will continue to work to safeguard the health and safety of U.S. consumers by monitoring the marketplace and taking action when companies sell products that threaten public health.”

However, companies and consumers have known of this growing issue before. Over 300 cases of harmful ingestion of copycat products were reported from 2021 to 2023, which led to the FDA taking action. These effects, also documented in children, include hallucinations, vomiting, anxiety, and loss of consciousness.

Moreover, the process of synthesizing delta-8 THC could potentially leave impurities or variations in these items, which could result in more harm. To address these problems, the agencies are working to remove these “foods” from shelves.

“Companies that market and sell edible THC products that are easily mistaken for snacks and candy are not only acting illegally, but they are also putting the health of young children at risk,” explained Samuel Levine, director of the FTC’s Bureau of Consumer Protection. “Those that prioritize profits in front of children’s safety are at serious risk of legal action.”

The companies must submit written action plans within 15 days detailing how they will correct the issue. Failure to do so will result in further legal action.

07/18/2024

Cannabis drinks: How do they compare to alcohol?
Posted July 18, 2024 on Harvard Health Publishing

ImageCannabis drinks: How do they compare to alcohol?
In States Where Ma*****na Is Legal, Beverages Infused with THC or CBD Are Sold.
In states where ma*****na is legal, beverages infused with THC or CBD are sold –– here's what to know.

More than half of Americans live in states where recreational cannabis is legal. While alcohol remains the most-used drug in the US, daily cannabis use has actually outpaced daily drinking, according to a study following four decades of consumption trends. Changing drinking habits and new products likely play a role.

Are you rethinking drinking habits?
Growing interest in Dry January and the sober curious movement suggests many people — especially younger adults — are rethinking drinking habits. Sales of alcohol-free beverages have been on the rise. One popular new category in that mix is cannabis-infused beverages, says Dr. Staci Gruber, an associate professor of psychiatry at Harvard Medical School who directs the Ma*****na Investigations for Neuroscientific Discovery (MIND) Program at McLean Hospital.

"People are interested in an experience that allows them to relax and enjoy themselves. Some are leaning into cannabis drinks as part of the 'Cali sober' trend," says Dr. Gruber.

(Cali — or California — sober is an informal term used to describe people who abstain from alcohol, or just moderate their drinking, and avoid drugs other than cannabis. Some people include psychedelic drugs such psilocybin and L*D in their definition of Cali sober).

What are cannabis-infused drinks?
First, a brief primer on cannabis (ma*****na). It comes from the Cannabis sativa plant, which contains more than 100 chemical compounds known as cannabinoids. These compounds interact with chemicals and receptors in the human brain.

The most familiar cannabinoid is delta-9-tetrahydrocannabinol (THC), which produces intoxication or euphoria. For some people, it also helps ease pain and nausea.
Another is cannabidiol (CBD), which is not intoxicating and has a number of potential medical uses, including anxiety-relieving properties.
Varieties of cannabis that contain low levels of THC (less than 0.3%) are classified as h**p, while those with more than 0.3% THC are considered cannabis. However, the type and amount of cannabinoids that different cannabis-based products claim to contain vary widely — and the labels aren't necessarily accurate, says Dr. Gruber.

Many cannabis-infused drinks list THC as an ingredient, and while there is no standard dose, 5 milligrams (mg) is typically used in research studies of the drug. Some "low-dose" beverages contain 2 to 4 mg of THC in an 8-ounce container. Other products can contain as much as 200 mg of THC. The drinks may also contain caffeine, alcohol, or other substances.

State laws vary on whether and where these drinks can be sold and on age restrictions.

How do cannabis drinks differ from edibles?
Edibles are foods containing cannabis, such as gummies, brownies, or cookies.

The cannabinoids found in beverages are specially formulated to dissolve in liquid. This means they are more easily and rapidly absorbed into the body's soft tissues.

"Some people say they feel the effects of cannabis-infused drinks within 15 to 20 minutes, which is much faster than when people eat a cannabis gummie or brownie," says Dr. Gruber. Those products take at least 30 to 90 minutes to take effect because they must be digested and then processed through your liver, she explains.

How do the effects of cannabis drinks compare with alcoholic drinks?
While everyone is different, people generally know how they're going to react if they drink, say, a light beer or two gin and tonics, says Dr. Gruber. But people are less familiar with the effects of cannabis in general — and of cannabis beverages in particular. That's compounded by the varied amounts, mixtures, and other ingredients different drinks may contain.

If you down one cannabis drink and don't wait long enough to feel the effects and have one or two more, you can double or triple your THC dose very quickly. "You can go from an experience that's reasonably pleasant to one that's not," says Dr. Gruber.

Some people feel fine after small and sometimes even large amounts of THC. Others find even small amounts intolerable. "They may feel uneasy or anxious and their heart rate and blood pressure may rise. Nausea and vomiting are also possible, and some people even become paranoid and agitated," says Dr. Gruber.

Are older adults more likely to experience unpleasant effects?
Possibly. Older adults may be more vulnerable to these unpleasant effects, in part because drug metabolism slows with age. After recreational cannabis became legal to sell in California, cannabis-related emergency department visits increased in older adults. The same trend occurred in Canada, as documented in a recent study in JAMA Internal Medicine.

This isn't to suggest that cannabis drinks are more risky than alcohol, which has many unhealthy effects. Still, there are generally more unknowns with cannabis drinks, says Dr. Gruber.

"If you are interested in trying it and it is legal for you to do so, be mindful about controlling the experience until you know how a particular product affects you," she says.

07/18/2024

Study Finds Immediate Anxiety and Depression Relief from Cannabis Use.
Consumers report reductions in their feelings of anxiety and depression immediately following their ma*****na use, according to data published in the journal Cannabis.

Investigators affiliated with Florida Gulf Coast University assessed the short-term effects of cannabis on symptoms of anxiety and depression in a cohort of 418 subjects. Study participants self-administered cannabis at home and reported symptom changes in real-time on a mobile software application. Researchers evaluated data from 9,966 sessions.

The study’s authors determined, “[B]oth depression and anxiety symptoms significantly decreased after cannabis use in general; results at the user level of analysis showed that the majority of users experienced positive relief outcomes.”

They concluded: “[These results] replicate previous work which has shown decreases in depression and anxiety symptomatology following real-time cannabis consumption. … Our results … speak to the potential of cannabis to combat acute depression and anxiety with a rapid onset of self-reported relief.”

Survey data finds that those who consume cannabis for purposes of self-medication most frequently report doing so to address pain, anxiety, sleep disturbances, and depression.

07/17/2024

Reggae star Ziggy Marley heading to Tucson

Reggae great Ziggy Marley brings his “Circle of Peace Tour” to Fox Tucson theatre on Tuesday, July 23.

Ziggy Marley, son of the late reggae royalty Bob Marley, brings his “Circle of Peace Tour” to Fox Tucson Theatre, 17 W. Congress St., on Tuesday, July 23.

Marley comes here months after the release of “One Love,” a biopic of his father that he co-produced. In his 40-year career, the Emmy- and Grammy-winning musician, producer, humanitarian and activist has fused funk, blues and rock with the reggae of his native Jamaica.

He comes here with the Boston-born funk jam band Lettuce, which was among the headliners of the 16th annual Gem & Jam Festival at the Pima County Fairgrounds in late January.

07/17/2024

Science of Smokeability Study
Get Paid to Smoke Joints: Pioneering Cannabis Study Seeks Participants to Advance Smoking Standards
6/18/2024 Guest Contribution
Ever wonder what makes a perfect puff?

As cannabis culture evolves, enthusiasts and experts alike are delving deeper into what truly enhances the smoking experience.

For decades, the cannabis industry has primarily focused its research efforts on maximizing crop yields and cannabinoid concentrations. However, a pioneering new study aims to shift that focus towards an often-overlooked aspect of the consumer experience – the art of smokeability.

Optimizing the Smoker’s Experience
Spearheaded by leading industry names DaySavers and Custom Cones USA, in collaboration with the Cannabis Research Coalition and the Network of Applied Pharmacognosy, “The Science of Smokeability” (SOS) promises to revolutionize our understanding of cultivation practices and their impact on the quality of the final smoking product.

At its core, the SOS study seeks to establish a direct link between various cultivation and processing variables, and their effect on the overall smoking experience.

By analyzing factors such as mineral content, nutrient levels, potential carcinogens, moisture content, ash composition, and smoke quality, the researchers aim to uncover the optimal conditions for producing a superior, more enjoyable smoke.

Custom Cones USA will also be conducting an innovative experiment focused on infused pre-rolls – one of the fastest rising categories in the pre-roll market. This study will evaluate various infusion techniques to determine which methods produce the hottest burns and most effectively deliver cannabinoids and terpenes.

Whether you prefer to smoke blunts or joints, or opt for innovative options like the pre rolled cross joint, the findings of this study could revolutionize the way you experience your favorite smoking products.

Get paid to smoke joints: study seeks participants to understand smokeability
DaySavers and Custom Cones USA: Elevating Industry Standards
As pioneers and experts in the pre-roll market, DaySavers and Custom Cones USA bring unparalleled expertise to this groundbreaking initiative.

DaySavers, the most compliant and tested pre-rolled cone and rolling paper brand, maintains the highest standards of product testing, adhering to the same rigorous protocols as regulated cannabis companies. This commitment to quality assurance has helped them create innovate pre roll blunts and other products that enhance smokeability and consumer satisfaction.

Custom Cones USA, a leading resource for pre rolled cones and renowned for its industry knowledge and innovative solutions, partnered with SOS to help facilitate advancements in cannabis quality and consistency, specifically regarding pre-roll production.

Their deep understanding of pre-roll manufacturing processes and consumer preferences will help translate the research findings into actionable insights for optimizing cultivation metrics and improving overall product quality.

A Collaborative Approach to Sustainable Progress
The study’s inclusive approach invites the broader cannabis community to participate through surveys and feedback, ensuring that the findings reflect diverse consumer perspectives and experiences.

The implications of the SOS study extend far beyond the realm of product development and consumer satisfaction. By establishing objective measurements of smoke quality and its correlation with cultivation practices, the research has the potential to inform future cannabis policies and regulations.

Through their partnership with ASTM Cannabis, an organization dedicated to developing industry-wide standards, the study’s findings will provide regulators with a scientific basis for informed decision-making. This collaborative effort could pave the way for a safer, more sustainable, and consistently high-quality future for smokable cannabis products across the industry.

Research into the smokeability of cannabis
Your Chance to Shape the Future of Cannabis
The researchers are offering you a unique opportunity to actively contribute to this groundbreaking initiative.

200 randomly selected individuals will receive complimentary pre-rolls and be compensated with $4.20 for providing qualitative feedback through a comparative survey. Whether you’re a seasoned blunt roller or brand new to cannabis, your input could shape the future of smoking experiences.

The SOS is an opportunity to play a pivotal role in shaping the future of the cannabis industry. By lending your expertise as a seasoned consumer, you can directly influence the study’s outcomes and contribute to the advancement of smokeability standards.

For those not selected for the paid opportunity, the study still welcomes your participation through various surveys throughout the research process. Every perspective and experience you share holds the potential to enrich the study’s findings and drive positive change within the industry.

As the cannabis industry continues to evolve, collaborative efforts like the SOS study are crucial in promoting quality, consistency, and responsible practices. By bridging the gap between academia, industry leaders, and the community, initiatives like this have the potential to shape the future of cannabis cultivation, manufacturing, and consumption on a global scale.

To learn more about the study and apply to participate, visit the DaySavers website.

AUTHORED BY:

Harrison Bard

07/17/2024

Fri / Jul 12th by Graham Abbott
House Republicans voted this week to block the Biden Administration’s effort to move cannabis from Schedule I to Schedule III under the Controlled Substances Act.


Lawmakers in the U.S. House Appropriations Committee have voted to block the Biden Administration’s effort to move cannabis from Schedule I to Schedule III under federal law, Forbes reports.

The Republican-controlled committee on Tuesday approved an amendment to a Commerce, Justice, Science, and Related Agencies (CJS) funding bill that, if enacted, would block the Department of Justice (DOJ) from using any federal funds to reschedule or deschedule cannabis under the Controlled Substances Act (CSA).

In 2022, President Joe Biden (D) pardoned all federal cannabis possession charges and tasked top administration officials — including the Secretary of Health and Human Services and U.S. Attorney General — with reviewing the plant’s Schedule I status. In 2023, the U.S. Department of Health and Human Services recommended that cannabis be moved to Schedule III under federal law; the rescheduling plan was formally announced by the president in May of this year. Ultimately, if cannabis were moved to Schedule III, it would remain federally illegal but would be significantly more accessible for research and medicinal purposes.

The House Appropriations Committee also rejected an amendment from Rep. Barbara Lee (D-CA) — who co-chairs the Congressional Cannabis Caucus — that sought to block the DOJ from spending resources to interfere with state-legal or tribal cannabis programs, including adult-use reforms, the report said.

House Republicans’ effort to block cannabis rescheduling and other reforms appears to run counter to public sentiment after a Pew Research poll in March found 88% of Americans believe that cannabis should be made legal for at least medical purposes, if not for adult use outright.

Meanwhile, according to a survey published in April, most Americans no longer believe cannabis use carries a stigma and 72% said that cannabis is only going to get more popular.
AUTHORED BY:

Graham Abbott

Based in Portland, Oregon, Graham is Ganjapreneur's Chief Editor. He has been writing about the legalization landscape since 2012 and has been contributing to Ganjapreneur since our official launch in 2014.

Address

6464 E. Tanque Verde Road
Tucson, AZ
85712

Opening Hours

Monday 7am - 10pm
Tuesday 8am - 10pm
Wednesday 8am - 10pm
Thursday 8am - 10pm
Friday 7am - 10pm
Saturday 8am - 10pm
Sunday 10am - 8pm

Telephone

+15202811587

Alerts

Be the first to know and let us send you an email when Greenmed Wellness Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Greenmed Wellness Center:

Share